NCT02766699 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02766699
Title	A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) (CerebralEDV)
Acronym	CerebralEDV
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Engeneic Pty Limited
Indications	glioblastoma
Therapies	EGFR(V)-EDV-Dox
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
John Hopkins Hospital		Baltimore	Maryland	21287	United States	Details
Lenox Hill Hospital, Northwell Health		New York	New York	10075	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02766699Clinical Trial Detail